Correlation Between Chevron Corp and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Chevron Corp and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chevron Corp and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chevron Corp and Pliant Therapeutics, you can compare the effects of market volatilities on Chevron Corp and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chevron Corp with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chevron Corp and Pliant Therapeutics.
Diversification Opportunities for Chevron Corp and Pliant Therapeutics
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Chevron and Pliant is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Chevron Corp and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Chevron Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chevron Corp are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Chevron Corp i.e., Chevron Corp and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Chevron Corp and Pliant Therapeutics
Considering the 90-day investment horizon Chevron Corp is expected to generate 3.65 times less return on investment than Pliant Therapeutics. But when comparing it to its historical volatility, Chevron Corp is 2.93 times less risky than Pliant Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 1,205 in Pliant Therapeutics on September 1, 2024 and sell it today you would earn a total of 175.00 from holding Pliant Therapeutics or generate 14.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Chevron Corp vs. Pliant Therapeutics
Performance |
| Timeline |
| Chevron Corp |
| Pliant Therapeutics |
Chevron Corp and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Chevron Corp and Pliant Therapeutics
The main advantage of trading using opposite Chevron Corp and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chevron Corp position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| Chevron Corp vs. Shell PLC ADR | Chevron Corp vs. BP PLC ADR | Chevron Corp vs. Equinor ASA ADR | Chevron Corp vs. Petrleo Brasileiro SA |
| Pliant Therapeutics vs. Tff Pharmaceuticals | Pliant Therapeutics vs. Eliem Therapeutics | Pliant Therapeutics vs. Inhibrx | Pliant Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |